04:26 PM EDT, 04/02/2025 (MT Newswires) -- Fluor (FLR) said late Wednesday it received a letter of intent from a pharmaceutical firm to provide engineering, procurement, and construction management services for its Lebanon, Indiana, mega-project.
Fluor said it will recognize the "multi-billion-dollar" reimbursable contract as a new award in Q1 of 2025.
According to the company, the facility will manufacture drugs for Type 2 diabetes and weight control.